{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:19:29Z","timestamp":1792667969649,"version":"4.5.0"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>IL-37 is a potent inhibitor of innate immunity by shifting the cytokine equilibrium away from excessive inflammation. Psoriasis is thought to be initiated by abnormal interactions between the cutaneous keratinocytes and systemic immune cells, triggering keratinocyte hyperproliferation. In the current study, we assessed IL-37 in two well-known psoriasis models: a human keratinocyte cell line (HaCaT) and the keratin 14 VEGF-A\u2013transgenic mouse model. First, we used the HaCaT cell line, which was transiently transfected with an overexpressing IL-37 vector, and tested the effect of IL-37 on these cells using a mixture of five proinflammatory cytokines. IL-37 was effective in suppressing the production of CXCL8, IL-6, and S100A7, which were highly upregulated by the mixture of five proinflammatory cytokines. Keratin 14 VEGF-A\u2013transgenic mice were treated with plasmid coding human IL-37 sequence\u2013formulated cationic liposomes, and we observed potent immunosuppressive effects over the 18-d period. In this model, we observed reduced systemic IL-10 levels, local IFN-\u03b3 gene transcripts, as well as mild mast cell infiltration into the psoriatic lesions of the mice. Immunohistochemical analysis indicated that IL-37 was expressed by effector memory T cells, as well as macrophages, in human psoriatic plaques. In conclusion, our studies strongly indicate that IL-37 plays a potent immunosuppressive role in the pathogenesis of both experimental psoriasis models in vitro and in vivo by downregulating proinflammatory cytokines. Importantly, our findings highlight new therapeutic strategies that can be designed to use this immunosuppressive anti-inflammatory cytokine in psoriasis and other inflammatory cutaneous diseases.<\/jats:p>","DOI":"10.4049\/jimmunol.1300047","type":"journal-article","created":{"date-parts":[[2014,1,23]],"date-time":"2014-01-23T04:55:34Z","timestamp":1390452934000},"page":"1815-1823","source":"Crossref","is-referenced-by-count":153,"title":["IL-37 Ameliorates the Inflammatory Process in Psoriasis by Suppressing Proinflammatory Cytokine Production"],"prefix":"10.1093","volume":"192","author":[{"given":"Xiu","family":"Teng","sequence":"first","affiliation":[{"name":"State Key Laboratory of Biotherapy, West China Hospital, Sichuan University , Chengdu, Sichuan 610041,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonglan","family":"Hu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Biotherapy, West China Hospital, Sichuan University , Chengdu, Sichuan 610041,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiong","family":"Wei","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Biotherapy, West China Hospital, Sichuan University , Chengdu, Sichuan 610041,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Biotherapy, West China Hospital, Sichuan University , Chengdu, Sichuan 610041,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Guan","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Biotherapy, West China Hospital, Sichuan University , Chengdu, Sichuan 610041,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Biotherapy, West China Hospital, Sichuan University , Chengdu, Sichuan 610041,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Biotherapy, West China Hospital, Sichuan University , Chengdu, Sichuan 610041,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ye","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Biotherapy, West China Hospital, Sichuan University , Chengdu, Sichuan 610041,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohua","family":"Deng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Biotherapy, West China Hospital, Sichuan University , Chengdu, Sichuan 610041,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Luo","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Biotherapy, West China Hospital, Sichuan University , Chengdu, Sichuan 610041,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nongyu","family":"Huang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Biotherapy, West China Hospital, Sichuan University , Chengdu, Sichuan 610041,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyan","family":"Sun","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Biotherapy, West China Hospital, Sichuan University , Chengdu, Sichuan 610041,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyan","family":"Xu","sequence":"additional","affiliation":[{"name":"Institute of Dermatology and Venereology, Sichuan Academy of Medical Sciences and Sichuan Provincial People\u2019s Hospital , Chengdu 610072,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xikun","family":"Zhou","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Biotherapy, West China Hospital, Sichuan University , Chengdu, Sichuan 610041,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxin","family":"Deng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Biotherapy, West China Hospital, Sichuan University , Chengdu, Sichuan 610041,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Carl Keith","family":"Edwards","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Biotherapy, West China Hospital, Sichuan University , Chengdu, Sichuan 610041,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiancheng","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Biotherapy, West China Hospital, Sichuan University , Chengdu, Sichuan 610041,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Dermatology and Venereology, Sichuan Academy of Medical Sciences and Sichuan Provincial People\u2019s Hospital , Chengdu 610072,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaijun","family":"Cui","sequence":"additional","affiliation":[{"name":"Cardiology Department, West China Hospital, Sichuan University , Chengdu, Sichuan 610041,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuquan","family":"Wei","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Biotherapy, West China Hospital, Sichuan University , Chengdu, Sichuan 610041,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Biotherapy, West China Hospital, Sichuan University , Chengdu, Sichuan 610041,","place":["People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,2,15]]},"reference":[{"key":"2025032404122116300_r1","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"2025032404122116300_r2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1684\/ecn.2011.0288","article-title":"IL-37: a new anti-inflammatory cytokine of the IL-1 family","volume":"22","author":"Boraschi","year":"2011","journal-title":"Eur. Cytokine Netw."},{"key":"2025032404122116300_r3","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.1944","article-title":"IL-37 is a fundamental inhibitor of innate immunity","volume":"11","author":"Nold","year":"2010","journal-title":"Nat. Immunol."},{"key":"2025032404122116300_r4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1006\/cyto.2002.0873","article-title":"Interleukin-1F7B (IL-1H4\/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production","volume":"18","author":"Kumar","year":"2002","journal-title":"Cytokine"},{"key":"2025032404122116300_r5","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.4049\/jimmunol.180.8.5477","article-title":"The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines","volume":"180","author":"Sharma","year":"2008","journal-title":"J. Immunol."},{"key":"2025032404122116300_r6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1042\/BJ20040217","article-title":"Interleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide","volume":"381","author":"Bufler","year":"2004","journal-title":"Biochem. J."},{"key":"2025032404122116300_r7","doi-asserted-by":"crossref","first-page":"16711","DOI":"10.1073\/pnas.1111982108","article-title":"Interleukin 37 expression protects mice from colitis","volume":"108","author":"McNamee","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032404122116300_r8","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1100\/2011\/968479","article-title":"In vivo expression of interleukin-37 reduces local and systemic inflammation in concanavalin A-induced hepatitis","volume":"11","author":"Bulau","year":"2011","journal-title":"ScientificWorldJournal"},{"key":"2025032404122116300_r9","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1440-1746.2012.07187.x","article-title":"Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells","volume":"27","author":"Sakai","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"2025032404122116300_r10","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"2025032404122116300_r11","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nrrheum.2010.157","article-title":"Psoriasis: what we have learned from mouse models","volume":"6","author":"Wagner","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"2025032404122116300_r12","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature05663","article-title":"Pathogenesis and therapy of psoriasis","volume":"445","author":"Lowes","year":"2007","journal-title":"Nature"},{"key":"2025032404122116300_r13","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.immuni.2011.08.001","article-title":"Pivotal role of dermal IL-17-producing \u03b3\u03b4 T cells in skin inflammation","volume":"35","author":"Cai","year":"2011","journal-title":"Immunity"},{"key":"2025032404122116300_r14","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.immuni.2012.11.006","article-title":"IL-22 from T cells: better late than never","volume":"37","author":"Honda","year":"2012","journal-title":"Immunity"},{"key":"2025032404122116300_r15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd1607","article-title":"Psoriasis: emerging therapeutic strategies","volume":"4","author":"Gottlieb","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"2025032404122116300_r16","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1600-0625.2010.01089.x","article-title":"Reduction of different inflammatory cell types of the innate immune system in psoriatic skin during etanercept treatment","volume":"19","author":"de Groot","year":"2010","journal-title":"Exp. Dermatol."},{"key":"2025032404122116300_r17","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/j.1365-2133.2012.11063.x","article-title":"Alitretinoin abrogates innate inflammation in palmoplantar pustular psoriasis","volume":"167","author":"Irla","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"2025032404122116300_r18","doi-asserted-by":"crossref","first-page":"16493","DOI":"10.1073\/pnas.1113711108","article-title":"Cooling the fires of inflammation","volume":"108","author":"Kim","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032404122116300_r19","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.4049\/jimmunol.0902464","article-title":"Skin inflammation induced by the synergistic action of IL-17A, IL-22, oncostatin M, IL-1{alpha}, and TNF-{alpha} recapitulates some features of psoriasis","volume":"184","author":"Guilloteau","year":"2010","journal-title":"J. Immunol."},{"key":"2025032404122116300_r20","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.exppara.2008.12.015","article-title":"The role of liposome charge on immune response generated in BALB\/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63)","volume":"121","author":"Badiee","year":"2009","journal-title":"Exp. Parasitol."},{"key":"2025032404122116300_r21","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1084\/jem.20100559","article-title":"Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation","volume":"207","author":"Huggenberger","year":"2010","journal-title":"J. Exp. Med."},{"key":"2025032404122116300_r22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/toxsci\/kfn261","article-title":"Inflammatory biomarkers of sulfur mustard analog 2-chloroethyl ethyl sulfide-induced skin injury in SKH-1 hairless mice","volume":"108","author":"Tewari-Singh","year":"2009","journal-title":"Toxicol. Sci."},{"key":"2025032404122116300_r23","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/ncb2622","article-title":"MCUR1 is an essential component of mitochondrial Ca2+ uptake that regulates cellular metabolism","volume":"14","author":"Mallilankaraman","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"2025032404122116300_r24","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.4049\/jimmunol.181.6.3784","article-title":"TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells","volume":"181","author":"Trotta","year":"2008","journal-title":"J. Immunol."},{"key":"2025032404122116300_r25","doi-asserted-by":"crossref","first-page":"24719","DOI":"10.1074\/jbc.M005813200","article-title":"Smad proteins suppress CCAAT\/enhancer-binding protein (C\/EBP) beta- and STAT3-mediated transcriptional activation of the haptoglobin promoter","volume":"276","author":"Zauberman","year":"2001","journal-title":"J. Biol. Chem."},{"key":"2025032404122116300_r26","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"Gaffen","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"2025032404122116300_r27","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1128\/IAI.68.5.2418-2423.2000","article-title":"Transforming growth factor-\u03b2 inhibits lipopolysaccharide-stimulated expression of inflammatory cytokines in mouse macrophages through downregulation of activation protein 1 and CD14 receptor expression","volume":"68","author":"Imai","year":"2000","journal-title":"Infect. Immun."},{"key":"2025032404122116300_r28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.febslet.2010.11.031","article-title":"IL-8-induced neutrophil chemotaxis is mediated by Janus kinase 3 (JAK3)","volume":"585","author":"Henkels","year":"2011","journal-title":"FEBS Lett."},{"key":"2025032404122116300_r29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1359-6101(02)00027-8","article-title":"IL-6 in autoimmune disease and chronic inflammatory proliferative disease","volume":"13","author":"Ishihara","year":"2002","journal-title":"Cytokine Growth Factor Rev."},{"key":"2025032404122116300_r30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jbspin.2011.06.011","article-title":"Psoriatic arthritis in two patients with an inadequate response to treatment with tocilizumab","volume":"79","author":"Ogata","year":"2012","journal-title":"Joint Bone Spine"},{"key":"2025032404122116300_r31","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ni1496","article-title":"Interleukins 1\u03b2 and 6 but not transforming growth factor-\u03b2 are essential for the differentiation of interleukin 17-producing human T helper cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat. Immunol."},{"key":"2025032404122116300_r32","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"2025032404122116300_r33","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.4049\/jimmunol.0803721","article-title":"IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells","volume":"183","author":"Goodman","year":"2009","journal-title":"J. Immunol."},{"key":"2025032404122116300_r34","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1038\/jid.2009.169","article-title":"Association between IL13 polymorphisms and psoriatic arthritis is modified by smoking","volume":"129","author":"Duffin","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"2025032404122116300_r35","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1689","article-title":"Getting under the skin: the immunogenetics of psoriasis","volume":"5","author":"Bowcock","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"2025032404122116300_r36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.0022-202X.2004.22719.x","article-title":"S100 proteins in the epidermis","volume":"123","author":"Eckert","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"2025032404122116300_r37","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.4049\/jimmunol.181.2.1499","article-title":"Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15","volume":"181","author":"Wolf","year":"2008","journal-title":"J. Immunol."},{"key":"2025032404122116300_r38","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.coph.2009.04.008","article-title":"Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity","volume":"9","author":"Sanjabi","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"2025032404122116300_r39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/gut.50.2.191","article-title":"Treatment of Crohn\u2019s disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma","volume":"50","author":"Tilg","year":"2002","journal-title":"Gut"},{"key":"2025032404122116300_r40","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.4049\/jimmunol.165.5.2783","article-title":"Proinflammatory effects of IL-10 during human endotoxemia","volume":"165","author":"Lauw","year":"2000","journal-title":"J. Immunol."},{"key":"2025032404122116300_r41","first-page":"285","article-title":"Clinical, pathological and immunological features of psoriatic-like lesions affecting keratin 14-vascular endothelial growth factor transgenic mice","volume":"26","author":"Canavese","year":"2011","journal-title":"Histol. Histopathol."},{"key":"2025032404122116300_r42","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0165-2478(03)00025-7","article-title":"Elevated rate of Thelper1 (T(H)1) lymphocytes and serum IFN-gamma levels in psoriatic patients","volume":"86","author":"Szegedi","year":"2003","journal-title":"Immunol. Lett."},{"key":"2025032404122116300_r43","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/jid.2009.59","article-title":"The IL-23\/Th17 axis in the immunopathogenesis of psoriasis","volume":"129","author":"Di Cesare","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"2025032404122116300_r44","doi-asserted-by":"crossref","first-page":"13723","DOI":"10.1073\/pnas.212519099","article-title":"A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity","volume":"99","author":"Bufler","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032404122116300_r45","doi-asserted-by":"crossref","first-page":"ii87","DOI":"10.1136\/ard.2004.032276","article-title":"Psoriasis treatment: current and emerging directed therapies","volume":"64","author":"Winterfield","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"2025032404122116300_r46","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nm804","article-title":"Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease","volume":"9","author":"Ghoreschi","year":"2003","journal-title":"Nat. Med."},{"key":"2025032404122116300_r47","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00403-008-0874-x","article-title":"Is there a role for mast cells in psoriasis?","volume":"300","author":"Harvima","year":"2008","journal-title":"Arch. Dermatol. Res."},{"key":"2025032404122116300_r48","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.clindermatol.2007.08.012","article-title":"Immunopathogenesis and role of T cells in psoriasis","volume":"25","author":"Ghoreschi","year":"2007","journal-title":"Clin. Dermatol."},{"key":"2025032404122116300_r49","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1046\/j.1365-4362.2001.01262.x","article-title":"Mast cell density and IL-8 expression in nonlesional and lesional psoriatic skin","volume":"40","author":"Jiang","year":"2001","journal-title":"Int. J. Dermatol."},{"key":"2025032404122116300_r50","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2249.2012.04618.x","article-title":"Experimentally induced psoriatic lesion associates with interleukin (IL)-6 in mast cells and appearance of dermal cells expressing IL-33 and IL-6 receptor","volume":"169","author":"Suttle","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"2025032404122116300_r51","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4049\/jimmunol.1100123","article-title":"Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis","volume":"187","author":"Lin","year":"2011","journal-title":"J. Immunol."},{"key":"2025032404122116300_r52","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/intimm\/dxn068","article-title":"TPA induction leads to a Th17-like response in transgenic K14\/VEGF mice: a novel in vivo screening model of psoriasis","volume":"20","author":"Hvid","year":"2008","journal-title":"Int. Immunol."},{"key":"2025032404122116300_r53","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/cei.12061","article-title":"Epithelial expression of interleukin-37b in inflammatory bowel disease","volume":"172","author":"Imaeda","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"2025032404122116300_r54","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nm1605","article-title":"\u03b11\u03b21 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis","volume":"13","author":"Conrad","year":"2007","journal-title":"Nat. Med."},{"key":"2025032404122116300_r55","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.4049\/jimmunol.176.7.4431","article-title":"The vast majority of CLA+ T cells are resident in normal skin","volume":"176","author":"Clark","year":"2006","journal-title":"J. Immunol."},{"key":"2025032404122116300_r56","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1038\/jid.2011.139","article-title":"Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin","volume":"131","author":"Bovenschen","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"2025032404122116300_r57","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/jid.2009.247","article-title":"Skin-resident T cells: the ups and downs of on site immunity","volume":"130","author":"Clark","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"2025032404122116300_r58","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1172\/JCI29441","article-title":"Misbehaving macrophages in the pathogenesis of psoriasis","volume":"116","author":"Clark","year":"2006","journal-title":"J. Clin. Invest."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/192\/4\/1815\/62510070\/1300047.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/192\/4\/1815\/62510070\/1300047.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T05:52:17Z","timestamp":1742795537000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/192\/4\/1815\/7996509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,2,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1300047","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,2]]},"published":{"date-parts":[[2014,2]]}}}